Clinical Trial Update: Fase II Study With BRB for Non-Hodgkin Lymphoplasmacytic Lymphoma/Waldenstrom Macroglobulinemia's [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for BRB in Waldenström's macroglobulinemia (non-Hodgkin lymphoplasmacytic lymphoma) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Waldenström Macroglobulinemia

Drugs mentioned

• BRB

Snippet

Sponsor: Fondazione Italiana Linfomi - ETS | Conditions: Waldenstrom's Macroglobulinemia | Phase 2 | Status: COMPLETED